Systematic review and meta-analysis of the effectiveness of commercially available vaccines against bovine herpesvirus, Bovine viral diarrhea virus, Bovine respiratory syncytial virus, And parainfluenza type 3 virus for mitigation of bovine respiratory disease complex in cattle

Journal of the American Veterinary Medical Association

Volumn 246, Issue 1, 2015, Pages 126-142

  Theurer, Miles E ^a   Larson, Robert L ^a   White, Brad J ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOS; BOVINAE; BOVINE HERPESVIRUS 1; BOVINE RESPIRATORY SYNCYTIAL VIRUS; BOVINE VIRAL DIARRHEA VIRUS 1; HERPESVIRIDAE;

VIRUS VACCINE;

ANIMAL; BOVINE; BOVINE HERPESVIRUS 1; BOVINE RESPIRATORY DISEASE COMPLEX; CLASSIFICATION; IMMUNOLOGY; META ANALYSIS; RETRACTED ARTICLE; RNA VIRUS; VIROLOGY; VIRUS;

ANIMALS; BOVINE RESPIRATORY DISEASE COMPLEX; CATTLE; HERPESVIRUS 1, BOVINE; RNA VIRUSES; VIRAL VACCINES; VIRUSES;

EID: 84918822858     PISSN: 00031488     EISSN: 1943569X     Source Type: Journal    
DOI: 10.2460/javma.246.1.126     Document Type: Article

References (41)

1. Terrell SP, Thomson DU, Wileman BW, et al. A survey to describe current feeder cattle health and well-being program rec- ommendations made by feedlot veterinary consultants in the United States and Canada. Bovine Pract 2011;45(2):140-148.
2. Nickell JS, White BJ. Metaphylactic antimicrobial therapy for bovine respiratory disease in stocker and feedlot cattle. Vet Clin North Am Food Anim Pract 2010;26:285-301.
3. USDA APHIS. Part IV: health and health management on US feedlots with a capacity of 1,000 or more head. Fort Collins, Colo: National Animal Health Monitoring System, 2011.
4. O’Connor AM, Coetzee JF, da Silva N, et al. A mixed treatment comparison meta-analysis of antibiotic treatments for bovine respiratory disease. Prev Vet Med 2013;110:77-87.
5. West K, Petrie L, Konoby C, et al. The efficacy of modified-live bovine respiratory syncytial virus vaccines in experimentally in- fected calves. Vaccine 1999;18:907-919.
6. Edwards TA. Control methods for bovine respiratory disease for feedlot cattle. Vet Clin North Am Food Anim Pract 2010;26:273-284.
7. Larson RL, Step DL. Evidence-based effectiveness of vaccination against Mannheimia haemolytica, Pasteurella multocida, and His- tophilus somni in feedlot cattle for mitigating the incidence and effect of bovine respiratory disease complex. Vet Clin North Am Food Anim Pract 2012;28:97-106.
8. Dohoo IR, Martin W, Stryhn H. Veterinary epidemiologic research. Charlottetown, NC: AVC Inc, 2003.
9. Stilwell G, Matos M, Carolino N, et al. Effect of a quadrivalent vaccine against respiratory virus on the incidence of respiratory disease in weaned beef calves. Prev Vet Med 2008;85:151-157.
10. Makoschey B, Bielsa JM, Oliviero L, et al. Field efficacy of combination vaccines against bovine respiratory pathogens in calves. Acta Vet Hung 2008;56:485-493.
11. Windeyer MC, Leslie KE, Godden SM, et al. The effects of viral vaccination of dairy heifer calves on the incidence of respiratory disease, mortality, and growth. J Dairy Sci 2012;95:6731-6739.
12. Howard CJ, Stott EJ, Thomas LH, et al. Protection against respiratory disease in calves induced by vaccines containing respi- ratory syncytial virus, parainfluenza type 3 virus, Mycoplasma bovis and M dispar. Vet Rec 1987;121:372-376.
13. Ellis JA, Gow SP, Goji N, et al. Efficacy of a combination viral vaccine for protection of cattle against experimental infection with field isolates of bovine herpesvirus-1. J Am Vet Med Assoc 2009;235:563-572.
14. Ellis J, Waldner C, Rhodes C, et al. Longevity of protective immunity to experimental bovine herpesvirus-1 infection following inoculation with a combination modified-live virus vaccine in beef calves. J Am Vet Med Assoc 2005;227:123-128.
15. Fairbanks KF, Campbell J, Chase CC. Rapid onset of protection against infectious bovine rhinotracheitis with a modified-live virus multivalent vaccine. Vet Ther 2004;5:17-25.
16. Xue W, Ellis J, Mattick D, et al. Immunogenicity of a modifiedlive virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluen- za-3 virus, and bovine respiratory syncytial virus when adminis- tered intranasally in young calves. Vaccine 2010;28:3784-3792.
17. Salt JS, Thevasagayam SJ, Wiseman A, et al. Efficacy of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV and BRSV in experimentally infected calves. Vet J 2007;174:616-626.
18. Peters AR, Thevasagayam SJ, Wiseman A, et al. Duration of immunity of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV, and BRSV in experimentally in- fected calves. Prev Vet Med 2004;66:63-77.
19. Xue W, Mattick D, Smith L. Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infec- tious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus. Vaccine 2011;29:4657-4662.
20. Kelling CL, Hunsaker BD, Steffen DJ, et al. Characterization of protection from systemic infection and disease by use of a modified-live noncytopathic bovine viral diarrhea virus type 1 vaccine in experimentally infected calves. Am J Vet Res 2005;66:1785-1791.
21. Kelling CL, Hunsaker BD, Steffen DJ, et al. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves. Am J Vet Res 2007;68:788-796.
22. Palomares RA, Givens MD, Wright JC, et al. Evaluation of the onset of protection induced by a modified-live virus vaccine in calves challenge inoculated with type 1b bovine viral diarrhea virus. Am J Vet Res 2012;73:567-574.
23. Stevens ET, Brown MS, Burdett WW, et al. Efficacy of a nonadjuvanted, modified-live virus vaccine in calves with maternal antibodies against a virulent bovine viral diarrhea virus type 2a challenge seven months following vaccination. Bovine Pract 2011;45(1):23-31.
24. Cravens RL. Clinical response of feeder calves under direct IBR and BVD virus challenge: a comparison of two vaccines and negative control. Bovine Pract 1991;26(1):154-158.
25. Ellis JA, Gow SP, Goji N. Response to experimentally induced infection with bovine respiratory syncytial virus following intranasal vaccination of seropositive and seronegative calves. J Am Vet Med Assoc 2010;236:991-999.
26. West K, Petrie L, Haines DM, et al. The effect of formalininactivated vaccine on respiratory disease associated with bovine respiratory syncytial virus infection in calves. Vaccine 1999;17:809-820.
27. Ellis J, Gow S, West K, et al. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for par- enteral administration. J Am Vet Med Assoc 2007;230:233-243.
28. Vangeel I, Antonis A, Fluess M, et al. Efficacy of a modified live intranasal bovine respiratory syncytial virus vaccine in a 3-week old calves experimentally challenged with BRSV. Vet J 2007;174:627-635.
29. Woolums AR, Brown CC, Brown JC Jr, et al. Effects of a single intranasal dose of modified-live bovine respiratory syncytial virus vaccine on resistance to subsequent viral challenge in calves. Am J Vet Res 2004;65:363-372.
30. Ellis J, West K, Konoby C, et al. Efficacy of an inactivated respiratory syncytial virus vaccine in calves. J Am Vet Med Assoc 2001;218:1973-1980.
31. Ellis JA, West KH, Waldner C, et al. Efficacy of a saponin-adjuvanted inactivated respiratory syncytial virus vaccine in calves. Can Vet J 2005;46:155-162.
32. Bryson DG, Adair BM, McNulty MS, et al. Studies on the efficacy of intranasal vaccination for the prevention of experimentally induced parainfluenza type 3 virus pneumonia in calves. Vet Rec 1999;145:33-39.
33. Van Donkersgoed J, Janzen ED, Townsend H, et al. Five field trials on the efficacy of bovine respiratory syncytial virus vaccine. Can Vet J 1990;31:93-100.
34. MacGregor S, Wray MI. The effect of bovine respiratory syncytial virus vaccination on health, feedlot performance and carcass characteristics of feeder cattle. Bovine Pract 2004;38(1):162-170.
35. Wildman BK, Perrett T, Abutarbush SM, et al. A comparison of 2 vaccination programs in feedlot calves at ultra-high risk of de- veloping undifferentiated fever/bovine respiratory disease. Can Vet J 2008;49:463-472.
36. Schunicht OC, Booker CW, Jim GK, et al. Comparison of a multivalent viral vaccine program versus a univalent viral vaccine program on animal health, feedlot performance, and carcass characteristics of feedlot calves. Can Vet J 2003;44:43-50.
37. Bryant TC, Rogers KC, Stone ND, et al. Effect of viral respiratory vaccine treatment on performance, health and carcass traits of auction-origin feeder steers. Bovine Pract 2008;42(2):98-103.
38. Brock KV, Widel P, Walz P, et al. Onset of protection from experimental infection with type 2 bovine viral diarrhea virus following vaccination with a modified-live vaccine. Vet Ther 2007;8:88-96.
39. Tripp HM, Step DL, Krehbiel CR, et al. Evaluation of outcomes in beef cattle comparing preventive health protocols utilizing viral respiratory vaccines. Bovine Pract 2013;47(1):54-64.
40. Downey ED, Tait RG Jr, Mayes MS, et al. An evaluation of circulating bovine viral diarrhea virus type 2 maternal antibody level and response to vaccination in Angus calves. J Anim Sci 2013;91:4440-4450.
41. Perino LJ, Hunsaker BD. A review of bovine respiratory disease vaccine field efficacy. Bovine Pract 1997;31(1):59-66.